Successful use of rituximab in fibrillary glomerulopathy

Asad Chaudhary, Geeta Gyamlani, Nich L. Cossey, Patrick D. Walker, Barry Wall

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Fibrillary glomerulopathy (FG) can occur either alone or co-existing with other proteinuric glomerular disorders. FG has been associated with poor renal outcomes leading to End Stage Renal Disease (ESRD). Since FG is a relatively rare disorder, limited information is available concerning treatment protocols. We present two patients with FG who were treated with rituximab after they had already progressed to stage 3 chronic kidney disease (CKD) with worsening proteinuria. Rituximab therapy resulted in long-term stabilization of renal function.

Original languageEnglish (US)
Pages (from-to)1151-1154
Number of pages4
JournalRenal Failure
Volume36
Issue number7
DOIs
StatePublished - Jan 1 2014

Fingerprint

Kidney
Clinical Protocols
Chronic Renal Insufficiency
Proteinuria
Chronic Kidney Failure
Rituximab
Therapeutics

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Chaudhary, A., Gyamlani, G., Cossey, N. L., Walker, P. D., & Wall, B. (2014). Successful use of rituximab in fibrillary glomerulopathy. Renal Failure, 36(7), 1151-1154. https://doi.org/10.3109/0886022X.2014.918832

Successful use of rituximab in fibrillary glomerulopathy. / Chaudhary, Asad; Gyamlani, Geeta; Cossey, Nich L.; Walker, Patrick D.; Wall, Barry.

In: Renal Failure, Vol. 36, No. 7, 01.01.2014, p. 1151-1154.

Research output: Contribution to journalArticle

Chaudhary, A, Gyamlani, G, Cossey, NL, Walker, PD & Wall, B 2014, 'Successful use of rituximab in fibrillary glomerulopathy', Renal Failure, vol. 36, no. 7, pp. 1151-1154. https://doi.org/10.3109/0886022X.2014.918832
Chaudhary, Asad ; Gyamlani, Geeta ; Cossey, Nich L. ; Walker, Patrick D. ; Wall, Barry. / Successful use of rituximab in fibrillary glomerulopathy. In: Renal Failure. 2014 ; Vol. 36, No. 7. pp. 1151-1154.
@article{da130e1242c742ba97f866f38c55a730,
title = "Successful use of rituximab in fibrillary glomerulopathy",
abstract = "Fibrillary glomerulopathy (FG) can occur either alone or co-existing with other proteinuric glomerular disorders. FG has been associated with poor renal outcomes leading to End Stage Renal Disease (ESRD). Since FG is a relatively rare disorder, limited information is available concerning treatment protocols. We present two patients with FG who were treated with rituximab after they had already progressed to stage 3 chronic kidney disease (CKD) with worsening proteinuria. Rituximab therapy resulted in long-term stabilization of renal function.",
author = "Asad Chaudhary and Geeta Gyamlani and Cossey, {Nich L.} and Walker, {Patrick D.} and Barry Wall",
year = "2014",
month = "1",
day = "1",
doi = "10.3109/0886022X.2014.918832",
language = "English (US)",
volume = "36",
pages = "1151--1154",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Successful use of rituximab in fibrillary glomerulopathy

AU - Chaudhary, Asad

AU - Gyamlani, Geeta

AU - Cossey, Nich L.

AU - Walker, Patrick D.

AU - Wall, Barry

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Fibrillary glomerulopathy (FG) can occur either alone or co-existing with other proteinuric glomerular disorders. FG has been associated with poor renal outcomes leading to End Stage Renal Disease (ESRD). Since FG is a relatively rare disorder, limited information is available concerning treatment protocols. We present two patients with FG who were treated with rituximab after they had already progressed to stage 3 chronic kidney disease (CKD) with worsening proteinuria. Rituximab therapy resulted in long-term stabilization of renal function.

AB - Fibrillary glomerulopathy (FG) can occur either alone or co-existing with other proteinuric glomerular disorders. FG has been associated with poor renal outcomes leading to End Stage Renal Disease (ESRD). Since FG is a relatively rare disorder, limited information is available concerning treatment protocols. We present two patients with FG who were treated with rituximab after they had already progressed to stage 3 chronic kidney disease (CKD) with worsening proteinuria. Rituximab therapy resulted in long-term stabilization of renal function.

UR - http://www.scopus.com/inward/record.url?scp=84904595047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904595047&partnerID=8YFLogxK

U2 - 10.3109/0886022X.2014.918832

DO - 10.3109/0886022X.2014.918832

M3 - Article

VL - 36

SP - 1151

EP - 1154

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 7

ER -